Advanced search
Publication Cover
Future Neurology Volume 3, 2008 - Issue 6
Submit an article Journal homepage
71
Views
0
CrossRef citations to date
0
Altmetric
Review

Essential Function, Sophisticated Regulation and Pathological Impact of the Selective RNA-Binding Protein QKI in CNS Myelin Development

Katrina Bockbradera Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA30322, USA Tel.: +1 404 727 0351 Fax: +1 404 727 [email protected]View further author information
&
Yue Fengb Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA30322, USA Tel.: +1 404 727 0351 Fax: +1 404 727 [email protected]Correspondence[email protected] [email protected]
View further author information
Pages 655-668 | Published online: 28 Oct 2008

Bibliography

  • Chenard CA , RichardS: New implications for the QUAKING RNA binding protein in human disease.J. Neurosci. Res.86, 233–242 (2008).
  • McInnes LA , LauriatTL: RNA metabolism and dysmyelination in schizophrenia.Neurosci. Biobehav. Rev.30, 551–561 (2006).
  • Larocque D , GalarneauA, LiuHN, ScottM, AlmazanG, RichardS: Protection of p27kip1 mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation.Nat. Neurosci.8, 27–33 (2005).
  • Ebersole TA , ChenQ, JusticeMJ, ArtztK: The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins.Nat. Genet.12, 260–265 (1996).
  • Hardy RJ , LoushinCL, FriedrichVLJret al.: Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J. Neurosci.16, 7941–7949 (1996).
  • Wu J , ZhouL, TonissenK, TeeR, ArtztK: The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm.J. Biol. Chem.274, 29202–29210 (1999).
  • Larocque D , PilotteJ, ChenTet al.: Nuclear retention of MBP mRNAs in the quaking viable mice.Neuron36, 815–829 (2002).
  • Pilotte J , LarocqueD, RichardS: Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer.Genes Dev.15, 845–858 (2001).
  • Galarneau A , RichardS: Target RNA motif and target mRNAs of the Quaking STAR protein.Nat. Struct. Mol. Biol.12, 691–698 (2005).
  • Ryder SP , FraterLA, AbramovitzDL, GoodwinEB, WilliamsonJR: RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1.Nat. Struct. Mol. Biol.11, 20–28 (2004).
  • Noveroske JK , LaiL, GaussinVet al.: Quaking is essential for blood vessel development.Genesis32, 218–230 (2002).
  • Dawson MR , PolitoA, LevineJM, ReynoldsR: NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS.Mol. Cell. Neurosci.24, 476–488 (2003).
  • Hardy RJ : Molecular defects in the dysmyelinating mutant quaking.J. Neurosci. Res.51, 417–422 (1998).
  • Vernet C , ArtztK: STAR, a gene family involved in signal transduction and activation of RNA.Trends Genet.13, 479–484 (1997).
  • Zhang Y , LuZ, KuL, ChenY, WangH, FengY: Tyrosine phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism.EMBO J.22, 1801–1810 (2003).
  • Chen Y , TianD, KuL, OsterhoutDJ, FengY: The selective RNA-binding protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation.J. Biol. Chem.282, 23553–23560 (2007).
  • Sokolov BP : Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?Int. J. Neuropsychopharmacol.10, 547–555 (2007).
  • Karoutzou G , EmrichHM, DietrichDE: The myelin-pathogenesis puzzle in schizophrenia: a literature review.Mol. Psychiatry13, 245–260 (2008).
  • Segal D , KoschnickJR, SlegersLH, HofPR: Oligodendrocyte pathophysiology: a new view of schizophrenia.Int. J. Neuropsychopharmacol.10, 503–511 (2007).
  • Feng Y : Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction.Neurochem. Res.33(10), 1940–1949 (2008).
  • Aberg K , SaetreP, JareborgN, JazinE: Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia.Proc. Natl Acad. Sci. USA103, 7482–7487 (2006).
  • Aberg K , SaetreP, LindholmEet al.: Human QKI, a new candidate gene for schizophrenia involved in myelination.Am. J. Med. Genet. B. Neuropsychiatr. Genet.141, 84–90 (2006).
  • Haroutunian V , KatselP, DrachevaS, DavisKL: The human homolog of the qkI gene affected in the severe dysmyelination ‘quaking‘ mouse phenotype: downregulated in multiple brain regions in schizophrenia.Am. J. Psychiatry163, 1834–1837 (2006).
  • Lauriat TL , ShiueL, HaroutunianVet al.: Developmental expression profile of quaking, a candidate gene for schizophrenia, and its target genes in human prefrontal cortex and hippocampus shows regional specificity.J. Neurosci. Res.86, 785–796 (2008).
  • Larocque D , RichardS: QUAKING KH domain proteins as regulators of glial cell fate and myelination.RNA Biol.2, 37–40 (2005).
  • Lakiza O , FraterL, YooYet al.: STAR proteins quaking-6 and GLD-1 regulate translation of the homologues GLI1 and tra-1 through a conserved RNA 3´UTR-based mechanism.Dev. Biol.287, 98–110 (2005).
  • Volk T , IsraeliD, NirR, Toledano-KatchalskiH: Tissue development and RNA control: ‘HOW‘ is it coordinated?Trends Genet.24, 94–101 (2008).
  • Sidman S , DickieM, AppelS: Mutant mice (Quaking and Jimpy) with deficient myelination in the central nervous system.Science144, 309–311 (1964).
  • Campagnoni AT : Molecular biology of myelin proteins from the central nervous system.J. Neurochem.51, 1–14 (1988).
  • Cox RD , HugillA, ShedlovskyAet al.: Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene.Genomics57, 333–341 (1999).
  • Kondo T , FurutaT, MitsunagaKet al.: Genomic organization and expression analysis of the mouse qkI locus.Mamm. Genome10, 662–669 (1999).
  • Lorenzetti D , AntalffyB, VogelH, NoveroskeJ, ArmstrongD, JusticeM: The neurological mutant quaking(viable) is Parkin deficient.Mamm. Genome15, 210–217 (2004).
  • Lu Z , ZhangY, KuL, WangH, AhmadianA, FengY: The quakingviable mutation affects qkI mRNA expression specifically in myelin-producing cells of the nervous system.Nucleic Acids Res.31, 4616–4624 (2003).
  • Noveroske JK , HardyR, DapperJD, VogelH, JusticeMJ: A new ENU-induced allele of mouse quaking causes severe CNS dysmyelination.Mamm. Genome16, 672–682 (2005).
  • Zhao L , TianD, XiaM, MacklinWB, FengY: Rescuing qkV dysmyelination by a single isoform of the selective RNA-binding protein QKI.J. Neurosci.26, 11278–11286 (2006).
  • Saccomanno L , LoushinC, JanE, PunkayE, ArtztK, GoodwinEB: The STAR protein QKI-6 is a translational repressor.Proc. Natl Acad. Sci. USA96, 12605–12610 (1999).
  • Li Z , ZhangY, LiD, FengY: Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins.J. Neurosci.20, 4944–4953 (2000).
  • Wu JI , ReedRB, GrabowskiPJ, ArtztK: Function of quaking in myelination: regulation of alternative splicing.Proc. Natl Acad. Sci. USA99, 4233–4238 (2002).
  • Ryder SP , WilliamsonJR: Specificity of the STAR/GSG domain protein QKI: implications for the regulation of myelination.RNA10, 1449–1458 (2004).
  • Chen T , DamajBB, HerreraC, LaskoP, RichardS: Self-association of the single-KH-domain family members Sam68, GRP33, GLD-1, and QKI: role of the KH domain.Mol. Cell. Biol.17, 5707–5718 (1997).
  • Chen T , RichardS: Structure-function analysis of QKI: a lethal point mutation in mouse quaking prevents homodimerization.Mol. Cell. Biol.18, 4863–4871 (1998).
  • Hayes GM , CarriganPE, MillerLJ: Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas.Cancer Res.67, 2072–2080 (2007).
  • Rosenberg SS , PowellBL, ChanJR: Receiving mixed signals: uncoupling oligodendrocyte differentiation and myelination.Cell. Mol. Life Sci.64, 3059–3068 (2007).
  • Hardy RJ : QKI expression is regulated during neuron–glial cell fate decisions.J. Neurosci. Res.54, 46–57 (1998).
  • Casaccia-Bonnefil P , HardyRJ, TengKK, LevineJM, KoffA, ChaoMV: Loss of p27kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation.Development126, 4027–4037 (1999).
  • Wegner M , StoltCC: From stem cells to neurons and glia: a Soxist‘s view of neural development.Trends Neurosci.28, 583–588 (2005).
  • Durand B , FeroML, RobertsJM, RaffMC: p27kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation.Curr. Biol.8, 431–440 (1998).
  • Tikoo R , OsterhoutDJ, Casaccia-BonnefilP, SethP, KoffA, ChaoMV: Ectopic expression of p27kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest.J. Neurobiol.36, 431–440 (1998).
  • Tang XM , BeesleyJS, GrinspanJB, SethP, KamholzJ, CambiF: Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation.J. Cell Biochem.76, 270–279 (1999).
  • Vouyiouklis DA , BrophyPJ: Microtubule-associated protein MAP1B expression precedes the morphological differentiation of oligodendrocytes.J. Neurosci. Res.35, 257–267 (1993).
  • Fischer I , KonolaJ, CocharyE: Microtubule associated protein (MAP1B) is present in cultured oligodendrocytes and co-localizes with tubulin.J. Neurosci. Res.27, 112–124 (1990).
  • Zhao L , KuL, ChenY, XiaM, LoPrestiP, FengY: QKI binds MAP1B mRNA and enhances MAP1B expression during oligodendrocyte development.Mol. Biol. Cell17, 4179–4186 (2006).
  • Wu HY , DawsonMR, ReynoldsR, HardyRJ: Expression of QKI proteins and MAP1B identifies actively myelinating oligodendrocytes in adult rat brain.Mol. Cell.Neurosci.17, 292–302 (2001).
  • Deber CM , ReynoldsSJ: Central nervous system myelin: structure, function, and pathology.Clin. Biochem.24, 113–134 (1991).
  • Barbarese E : Spatial distribution of myelin basic protein mRNA and polypeptide in quaking oligodendrocytes in culture.J. Neurosci. Res.29, 271–281 (1991).
  • Fujita N , SatoS, KuriharaT, InuzukaT, TakahashiY, MiyatakeT: Developmentally regulated alternative splicing of brain myelin-associated glycoprotein mRNA is lacking in the quaking mouse.FEBS Lett.232, 323–327 (1988).
  • Lu Z , KuL, ChenY, FengY: Developmental abnormalities of myelin basic protein expression in fyn knock-out brain reveal a role of Fyn in posttranscriptional regulation.J. Biol. Chem.280, 389–395 (2005).
  • Wei Q , MiskiminsWK, MiskiminsR: The Sp1 family of transcription factors is involved in p27kip1-mediated activation of myelin basic protein gene expression.Mol. Cell. Biol.23, 4035–4045 (2003).
  • Marquardt T , PfaffSL: Cracking the transcriptional code for cell specification in the neural tube.Cell106, 651–654 (2001).
  • Gokhan S , Marin-HusstegeM, YungSY, FontanezD, Casaccia-BonnefilP, MehlerMF: Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression.J. Neurosci.25, 8311–8321 (2005).
  • Kubicki M , McCarleyRW, ShentonME: Evidence for white matter abnormalities in schizophrenia.Curr. Opin Psychiatry18, 121–134 (2005).
  • Havlioglu N , WangJ, FushimiKet al.: An intronic signal for alternative splicing in the human genome.PLoS ONE2, E1246 (2007).
  • Wang E , DimovaN, CambiF: PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes.Nucleic Acids Res.35, 4164–4178 (2007).
  • Baralle D , BaralleM: Splicing in action: assessing disease causing sequence changes.J. Med. Genet.42, 737–748 (2005).
  • Zhang MQ : Statistical features of human exons and their flanking regions.Hum. Mol. Genet.7, 919–932 (1998).
  • Garneau NL , WiluszJ, WiluszCJ: The highways and byways of mRNA decay.Nat. Rev. Mol. Cell Biol.8, 113–126 (2007).
  • Guhaniyogi J , BrewerG: Regulation of mRNA stability in mammalian cells.Gene265, 11–23 (2001).
  • Schlessinger J : SH2/SH3 signaling proteins.Curr. Opin. Genet. Dev.4, 25–30 (1994).
  • Gmeiner WH , HoritaDA: Implications of SH3 domain structure and dynamics for protein regulation and drug design.Cell Biochem. Biophys.35, 127–140 (2001).
  • Umemori H , SatoS, YagiT, AizawaS, YamamotoT: Initial events of myelination involve Fyn tyrosine kinase signalling.Nature367, 572–576 (1994).
  • Osterhout DJ , WolvenA, WolfRM, ReshMD, ChaoMV: Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.J. Cell Biol.145, 1209–1218 (1999).
  • Kramer EM , KleinC, KochT, BoytinckM, TrotterJ: Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination.J. Biol. Chem.274, 29042–29049 (1999).
  • Umemori H , KadowakiY, HirosawaKet al.: Stimulation of myelin basic protein gene transcription by Fyn tyrosine kinase for myelination.J. Neurosci.19, 1393–1397 (1999).
  • Seiwa C , SugiyamaI, YagiT, IguchiT, AsouH: Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system.Neurosci. Res.37, 21–31 (2000).
  • Sperber BR , Boyle-WalshEA, EnglekaMJet al.: A unique role for Fyn in CNS myelination.J. Neurosci.21, 2039–2047 (2001).
  • Goto J , TezukaT, NakazawaT, SagaraH, YamamotoT: Loss of Fyn tyrosine kinase on the C57BL/6 genetic background causes hydrocephalus with defects in oligodendrocyte development.Mol. Cell. Neurosci.38, 203–212 (2008).
  • Grant SG , KarlKA, KieblerMA, KandelER: Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice.Genes Dev.9, 1909–1921 (1995).
  • Lew J , HuangQQ, QiZet al.: A brain-specific activator of cyclin-dependent kinase 5.Nature371, 423–426 (1994).
  • Tsai LH , DelalleI, CavinessVS Jr, Chae T, Harlow E: p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature371, 419–423 (1994).
  • Miyamoto Y , YamauchiJ, ChanJRet al.: Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin.J. Cell Sci.120, 4355–4366 (2007).
  • Flores AI , NarayananSP, MorseENet al.: Constitutively active Akt induces enhanced myelination in the CNS.J. Neurosci.28, 7174–7183 (2008).
  • Fragoso G , HainesJD, RoberstonJ, PedrazaL, MushynskiWE, AlmazanG: p38 mitogen-activated protein kinase is required for central nervous system myelination.Glia55, 1531–1541 (2007).
  • Frost EE , ZhouZ, KrasneskyK, ArmstrongRC: Initiation of oligodendrocyte progenitor cell migration by a PDGF-A activated extracellular regulated kinase (ERK) signaling pathway.Neurochem. Res. (2008) (Epub ahead of print).
  • Cote J , BoisvertFM, BoulangerMC, BedfordMT, RichardS: Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1.Mol. Biol. Cell14, 274–287 (2003).
  • Li ZZ , KondoT, MurataTet al.: Expression of Hqk encoding a KH RNA binding protein is altered in human glioma.Jpn J. Cancer Res.93, 167–177 (2002).
  • Lindholm E , EkholmB, ShawSet al.: A schizophrenia-susceptibility locus at 6q25, in one of the world‘s largest reported pedigrees.Am. J. Hum. Genet.69, 96–105 (2001).
  • Tastemir D , DemirhanO, SertdemirY: Chromosomal fragile site expression in Turkish psychiatric patients.Psychiatry Res.144, 197–203 (2006).
  • McCullumsmith RE , GuptaD, BeneytoMet al.: Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.Schizophr. Res.90, 15–27 (2007).
  • Yeo G , HoonS, VenkateshB, BurgeCB: Variation in sequence and organization of splicing regulatory elements in vertebrate genes.Proc. Natl Acad. Sci. USA101, 15700–15705 (2004).
  • Fairbrother WG , YehRF, SharpPA, BurgeCB: Predictive identification of exonic splicing enhancers in human genes.Science297, 1007–1013 (2002).
  • Katsel P , DavisKL, HaroutunianV: Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study.Schizophr. Res.79, 157–173 (2005).
  • Hafner H : Onset and course of the first schizophrenic episode.Kaohsiung J. Med. Sci.14, 413–431 (1998).
  • Steen RG , MullC, McClureR, HamerRM, LiebermanJA: Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies.Br. J. Psychiatry188, 510–518 (2006).
  • Steinman L , MartinR, BernardC, ConlonP, OksenbergJR: Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.Annu. Rev. Neurosci.25, 491–505 (2002).
  • Howe CL : Immunological aspects of axon injury in multiple sclerosis.Curr. Top. Microbiol. Immunol.318, 93–131 (2008).
  • Vanderlocht J , HellingsN, HendriksJJ, StinissenP: Current trends in multiple sclerosis research: an update on pathogenic concepts.Acta Neurol. Belg.106, 180–190 (2006).
  • Seiwa C , YamamotoM, TanakaKet al.: Restoration of FcRg/Fyn signaling repairs central nervous system demyelination.J. Neurosci. Res.85, 954–966 (2007).
  • Ichimura K , MungallAJ, FieglerHet al.: Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH.Oncogene25, 1261–1271 (2006).
  • Sukumar S , WangS, HoangKet al.: Subtle overlapping deletions in the terminal region of chromosome 6q24.2-q26: three cases studied using FISH.Am. J. Med. Genet.87, 17–22 (1999).
  • Lim J , HaoT, ShawCet al.: A protein–protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.Cell125, 801–814 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.